92 related articles for article (PubMed ID: 27060894)
1. Structure-based designing of sordarin derivative as potential fungicide with pan-fungal activity.
Chakraborty B; Sejpal NV; Payghan PV; Ghoshal N; Sengupta J
J Mol Graph Model; 2016 May; 66():133-42. PubMed ID: 27060894
[TBL] [Abstract][Full Text] [Related]
2. Species-specific inhibition of fungal protein synthesis by sordarin: identification of a sordarin-specificity region in eukaryotic elongation factor 2.
Shastry M; Nielsen J; Ku T; Hsu MJ; Liberator P; Anderson J; Schmatz D; Justice MC
Microbiology (Reading); 2001 Feb; 147(Pt 2):383-390. PubMed ID: 11158355
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the mechanism of translational inhibition by the fungicide sordarin.
Chakraborty B; Mukherjee R; Sengupta J
J Comput Aided Mol Des; 2013 Feb; 27(2):173-84. PubMed ID: 23397219
[TBL] [Abstract][Full Text] [Related]
4. Sordarin derivatives induce a novel conformation of the yeast ribosome translocation factor eEF2.
Søe R; Mosley RT; Justice M; Nielsen-Kahn J; Shastry M; Merrill AR; Andersen GR
J Biol Chem; 2007 Jan; 282(1):657-66. PubMed ID: 17082187
[TBL] [Abstract][Full Text] [Related]
5. Identification of a putative sordarin binding site in Candida albicans elongation factor 2 by photoaffinity labeling.
Domínguez JM; Martin JJ
J Biol Chem; 2001 Aug; 276(33):31402-7. PubMed ID: 11402051
[TBL] [Abstract][Full Text] [Related]
6. The discovery of moriniafungin, a novel sordarin derivative produced by Morinia pestalozzioides.
Basilio A; Justice M; Harris G; Bills G; Collado J; de la Cruz M; Diez MT; Hernandez P; Liberator P; Nielsen kahn J; Pelaez F; Platas G; Schmatz D; Shastry M; Tormo JR; Andersen GR; Vicente F
Bioorg Med Chem; 2006 Jan; 14(2):560-6. PubMed ID: 16183294
[TBL] [Abstract][Full Text] [Related]
7. Mutations in ribosomal protein L10e confer resistance to the fungal-specific eukaryotic elongation factor 2 inhibitor sordarin.
Justice MC; Ku T; Hsu MJ; Carniol K; Schmatz D; Nielsen J
J Biol Chem; 1999 Feb; 274(8):4869-75. PubMed ID: 9988728
[TBL] [Abstract][Full Text] [Related]
8. Distribution of the antifungal agents sordarins across filamentous fungi.
Vicente F; Basilio A; Platas G; Collado J; Bills GF; González del Val A; Martín J; Tormo JR; Harris GH; Zink DL; Justice M; Kahn JN; Peláez F
Mycol Res; 2009; 113(Pt 6-7):754-70. PubMed ID: 19249360
[TBL] [Abstract][Full Text] [Related]
9. Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts.
Domínguez JM; Kelly VA; Kinsman OS; Marriott MS; Gómez de las Heras F; Martín JJ
Antimicrob Agents Chemother; 1998 Sep; 42(9):2274-8. PubMed ID: 9736548
[TBL] [Abstract][Full Text] [Related]
10. Two crystal structures demonstrate large conformational changes in the eukaryotic ribosomal translocase.
Jørgensen R; Ortiz PA; Carr-Schmid A; Nissen P; Kinzy TG; Andersen GR
Nat Struct Biol; 2003 May; 10(5):379-85. PubMed ID: 12692531
[TBL] [Abstract][Full Text] [Related]
11. A chemical genomic screen in Saccharomyces cerevisiae reveals a role for diphthamidation of translation elongation factor 2 in inhibition of protein synthesis by sordarin.
Botet J; Rodríguez-Mateos M; Ballesta JP; Revuelta JL; Remacha M
Antimicrob Agents Chemother; 2008 May; 52(5):1623-9. PubMed ID: 18285480
[TBL] [Abstract][Full Text] [Related]
12. Sordarin inhibits fungal protein synthesis by blocking translocation differently to fusidic acid.
Domínguez JM; Gómez-Lorenzo MG; Martín JJ
J Biol Chem; 1999 Aug; 274(32):22423-7. PubMed ID: 10428815
[TBL] [Abstract][Full Text] [Related]
13. Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis.
Justice MC; Hsu MJ; Tse B; Ku T; Balkovec J; Schmatz D; Nielsen J
J Biol Chem; 1998 Feb; 273(6):3148-51. PubMed ID: 9452424
[TBL] [Abstract][Full Text] [Related]
14. Domain movements of elongation factor eEF2 and the eukaryotic 80S ribosome facilitate tRNA translocation.
Spahn CM; Gomez-Lorenzo MG; Grassucci RA; Jørgensen R; Andersen GR; Beckmann R; Penczek PA; Ballesta JP; Frank J
EMBO J; 2004 Mar; 23(5):1008-19. PubMed ID: 14976550
[TBL] [Abstract][Full Text] [Related]
15. FR290581, a novel sordarin derivative: synthesis and antifungal activity.
Hanadate T; Tomishima M; Shiraishi N; Tanabe D; Morikawa H; Barrett D; Matsumoto S; Ohtomo K; Maki K
Bioorg Med Chem Lett; 2009 Mar; 19(5):1465-8. PubMed ID: 19196509
[TBL] [Abstract][Full Text] [Related]
16. Sordarin- An anti-fungal antibiotic with a unique modus operandi.
Shao Y; Molestak E; Su W; Stankevič M; Tchórzewski M
Br J Pharmacol; 2022 Mar; 179(6):1125-1145. PubMed ID: 34767248
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal P-protein stalk function is targeted by sordarin antifungals.
Gómez-Lorenzo MG; García-Bustos JF
J Biol Chem; 1998 Sep; 273(39):25041-4. PubMed ID: 9737960
[TBL] [Abstract][Full Text] [Related]
18. Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans.
Domínguez JM; Martín JJ
Antimicrob Agents Chemother; 1998 Sep; 42(9):2279-83. PubMed ID: 9736549
[TBL] [Abstract][Full Text] [Related]
19. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal P0 protein domain involved in selectivity of antifungal sordarin derivatives.
Santos C; Rodríguez-Gabriel MA; Remacha M; Ballesta JP
Antimicrob Agents Chemother; 2004 Aug; 48(8):2930-6. PubMed ID: 15273103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]